Technical Data

I7661-39A
Clone Type
Monoclonal
Host
Mouse
Source
Human
Isotype
IgG1,k
Clone Number
0.N.97 (4B7R)
Grade
Affinity Purified
Applications
FC IF IHC
Crossreactivity
Hu Po
Shipping Temp
Blue Ice
Storage Temp
-20°C
Mouse Anti-Integrin, beta1 (CD29, Very Late Antigen, VLAb1, Platelet gplla)

CD29 (integrin Beta-1/gpIIa) is a cell adhesion molecule appearing on platelets, as the common Beta subunit of the very late activation antigen (VLA), and as a component of various protein complexes binding to extracellular matrix proteins. The CD29 is expressed at the cell surface exclusively as part of a heterodimer, in association with one of at least nine different integrin alpha subunits (alpha1, alpha2, alpha3, alpha4, alpha5, alpha6, alpha7, alpha8, and alphav). With the exception of red blood cells and possible weak expression on granulocytes, CD29 is expressed on nearly all cell and tissue types.

Applications
Suitable for use in Flow Cytometry, Immunofluorescence, and Immunohistochemistry. Other applications have not been tested.
Recommended Dilutions
Immunohistochemistry: Frozen sections Optimal dilutions to be determined by the researcher.
Positive Control
Tonsil
Storage and Stability
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Immunogen
Human melanoma V+B2 cell line. Cellular Localization: Cell membrane
Form
Supplied as a liquid in 10mM PBS, pH 7.4, 0.2% BSA, 15mM sodium azide.
Purity
Purified by Protein G affinity chromatography.
Specificity
Recognizes human Integrin, beta1. Reacts with non-reduced protein of 110kD and a reduced protein of 130kD. Species Crossreactivity: porcine

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

References
1. Friedlander DR; Zagzag D; Shiff B; Cohen H; Allen JC; Kelly PJ; Grumet M. Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. Cancer Research, 1996, 56(8):1939-47.|2. Hieken TJ; Ronan SG; Farolan M; Shilkaitis AL; Das Gupta TK. Beta 1 integrin expression: a marker of lymphatic metastases in cutaneous malignant melanoma. Anticancer Res, 1996, 16(4B):2321-4.|3. Lanzafame S; Emmanuele C; Torrisi A. Correlation of alpha 2 beta 1 integrin expression with histological type and hormonal receptor status in breast carcinomas. Pathology, Research and Practice, 1996, 192(10):1031-8.|4. Price EA; Coombe DR; Murray JC. beta-1 Integrins mediate tumour cell adhesion to quiescent endothelial cells in vitro. British Journal of Cancer, 1996, 74(11):1762-6.|5. Shiokawa S; Yoshimura Y; Nagamatsu S; Sawa H; Hanashi H; Oda T; Katsumata Y; Koyama N; Nakamura Y. Expression of beta 1 integrins in human endometrial stromal and decidual cells. Journal of Clinical Endocrinology and Metabolism, 1996, 81(4):1533-40.|6. Marshall JF; Rutherford DC; McCartney AC; Mitjans F; Goodman SL; Hart IR. Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin. Journal of Cell Science, 1995, 108:1227-38.|7. el Gabalawy H; Wilkins J. Beta 1 (CD29) integrin expression in rheumatoid synovial membranes: an immunohistologic study of distribution patterns. Journal of Rheumatology, 1993, 20(2):231-7.|8. Marshall JF; Nesbitt SA; Helfrich MH; Horton MA; Polakova K; Hart IR. Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. International Journal of Cancer, 1991, 49(6):924-31.
USBio References
No references available
United States Biological | 4 Technology Way | Salem, MA 01970
Phone 800-520-3011 | Fax 978-594-8052 | Website www.usbio.net